Verrica Pharmaceuticals I... (VRCA)

AI Score

Unlock

0.49

0.02 (5.04%)

At close: Apr 25, 2025, 3:59 PM

0.46

-6.03%

After-hours: Apr 25, 2025, 05:15 PM EDT

Verrica Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q1 2017
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Mar 31, 2017
Cash & Equivalents	46.33M	22.96M	31.93M	48.94M	69.55M	84.31M	55.14M	59.95M	34.27M	32.47M	5.43M	10.41M	15.75M	20.44M	24.71M	44.1M	10.69M	17.2M	48.93M	54.49M	9.24M	10.6M	19.85M	24.43M	89.81M	38.31M	103.15M	27.48M	8.66M	-527K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	6.98M	8.97M	11.5M	54.6M	59.05M	65.42M	43.59M	54.78M	54.68M	30.69M	33.9M	52.78M	60.48M	58.9M	58.85M	79.54M	58.66M	n/a	n/a	n/a	1.05M
Long-Term Investments	n/a	n/a	n/a	4K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	376K	538K	453K	452K	452K	n/a	436K	369K	n/a	221K	469K	142K	n/a	264K	285K	947K	3.75M	1.36M	1.38M	1.38M	1.24M	34K	14K	14K	1.84M	14K	14K	472K	n/a	-527K
Receivables	77K	84K	10.21M	7.59M	4.42M	4.07M	173K	56K	487K	419K	218K	431K	n/a	n/a	n/a	11.5M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	6K	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	2.46M	2.58M	2.7M	2.5M	1.02M	279K	n/a	n/a	-487K	n/a	1.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.31M	2.56M	2.48M	2.34M	2.54M	3.07M	1.46M	3.09M	4.36M	3.52M	40M	40M	3.97M	3.66M	3.25M	n/a	2.18M	2.09M	3.72M	2.27M	2.97M	2.96M	985K	n/a	1.34M	1.7M	1.44M	n/a	n/a	n/a
Total Current Assets	51.18M	28.19M	47.32M	61.38M	77.53M	91.72M	56.78M	63.1M	39.12M	43.4M	57.34M	65.77M	74.33M	83.16M	93.37M	102.05M	65.47M	73.97M	83.34M	90.65M	64.98M	74.04M	79.74M	84.68M	89.81M	98.68M	104.59M	28.91M	9.08M	527K
Property-Plant & Equipment	2.58M	4.2M	4.24M	4.48M	3.62M	5.42M	4.99M	5.17M	5.61M	5.53M	5.63M	5.7M	5.8M	5.33M	5.37M	5.11M	4.94M	4.6M	2.52M	2.42M	2.2M	2M	1.5M	1.29M	255K	114K	112K	19K	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	2.96M	4.74M	4.69M	4.93M	4.07M	5.42M	5.42M	5.54M	5.61M	5.75M	6.09M	5.84M	5.8M	5.6M	5.66M	6.06M	8.68M	5.96M	3.9M	3.79M	3.44M	2.03M	1.51M	1.3M	2.1M	128K	126K	491K	n/a	-527K
Total Assets	54.13M	32.93M	52.01M	66.31M	81.6M	97.15M	62.2M	68.64M	44.72M	49.15M	63.44M	71.62M	80.13M	88.76M	99.03M	108.1M	74.15M	79.94M	87.24M	94.44M	68.42M	76.07M	81.25M	85.98M	91.91M	98.81M	104.72M	29.4M	9.08M	n/a
Account Payables	1.9M	966K	1.15M	2.53M	2.46M	1.93M	2.06M	575K	507K	137K	714K	531K	845K	904K	783K	878K	348K	179K	1.3M	1.1M	1.19M	1.01M	1.47M	1.14M	922K	1.07M	1.08M	611K	153K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	8.82M	n/a	n/a	n/a	-291K	n/a	n/a	n/a	n/a	n/a	n/a	500K	500K	n/a	n/a	n/a	n/a	n/a	1.68M	n/a	n/a	n/a	-7K	n/a	n/a
Short-Term Debt	12.94M	1.16M	1.05M	n/a	700K	347K	309K	n/a	297K	291K	42.29M	42M	41.69M	41.59M	41.25M	40.9M	35.51M	35.23M	34.84M	133K	130K	127K	124K	122K	n/a	n/a	n/a	7K	n/a	n/a
Other Current Liabilities	11.59M	15.07M	14.46M	8.92M	9.72M	3.15M	1.94M	538K	1.1M	1.09M	291K	459K	255K	1.91M	1.92M	1.76M	1.58M	1.58M	1.55M	1.36M	1.06M	2.03M	1.72M	269K	n/a	n/a	697K	n/a	n/a	n/a
Total Current Liabilities	29.01M	21.03M	20.05M	19.36M	17.02M	11.37M	5.73M	2.64M	3.46M	3.08M	45.71M	44.8M	46.05M	46.37M	45.28M	44.66M	39.48M	39M	38.7M	3.3M	3.35M	4.33M	4.28M	3.06M	2.48M	2.45M	3.13M	1.65M	616K	n/a
Long-Term Debt	30.98M	43.3M	42.75M	42.85M	42.87M	42.4M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	34.43M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	2.65M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	75K	75K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	34.98M	45.95M	45.26M	45.43M	44.81M	43.47M	1.07M	1.15M	1.23M	1.3M	1.39M	1.4M	1.47M	1.53M	1.59M	1.63M	35.31M	1.75M	75K	34.53M	58K	91K	124K	156K	n/a	n/a	n/a	n/a	n/a	n/a
Total Liabilities	63.99M	66.98M	65.31M	64.8M	61.83M	54.84M	6.8M	3.79M	4.69M	4.38M	47.1M	46.2M	47.52M	47.9M	46.87M	46.29M	41.17M	40.75M	38.77M	37.83M	3.41M	4.42M	4.41M	3.22M	2.48M	2.45M	3.13M	1.65M	616K	n/a
Total Debt	45.94M	47.11M	46.31M	46.44M	45.51M	43.82M	1.38M	1.45M	1.53M	1.59M	43.98M	43.65M	43.41M	43.12M	42.84M	42.53M	35.31M	36.98M	34.84M	34.59M	188K	218K	248K	278K	n/a	n/a	n/a	7K	n/a	n/a
Common Stock	9K	5K	4K	4K	4K	4K	4K	4K	4K	4K	3K	3K	3K	3K	3K	3K	3K	3K	3K	3K	3K	3K	3K	3K	3K	3K	3K	2K	2K	n/a
Retained Earnings	-307.03M	-290.82M	-267.96M	-250.78M	-230.45M	-205.83M	-181.03M	-170.04M	-163.45M	-157.52M	-157.6M	-147.44M	-138.97M	-129.43M	-116.6M	-104.82M	-103.89M	-90.91M	-80.42M	-71.01M	-61.19M	-53.55M	-47.47M	-40.46M	-33.08M	-27.01M	-20.27M	-14.31M	-12.44M	n/a
Comprehensive Income	n/a	n/a	n/a	-4K	0.00	n/a	0.00	n/a	n/a	-29K	-64K	-62K	-29K	-2K	-1K	3K	1K	6K	32K	20K	20K	27K	38K	11K	-17K	-7K	-104.72M	-36.5M	-15.51M	-2.66M
Shareholders Equity	-9.86M	-34.05M	-13.3M	1.51M	19.76M	42.3M	55.4M	64.85M	40.03M	44.77M	16.33M	25.42M	32.6M	40.85M	52.16M	61.81M	32.99M	39.18M	48.46M	56.61M	65.02M	71.65M	76.84M	82.76M	89.43M	96.35M	101.59M	27.75M	8.47M	125K
Total Investments	n/a	n/a	n/a	4K	n/a	n/a	n/a	n/a	n/a	6.98M	8.97M	11.5M	54.6M	59.05M	65.42M	43.59M	54.78M	54.68M	30.69M	33.9M	52.78M	60.48M	58.9M	58.85M	79.54M	58.66M	n/a	n/a	n/a	1.05M